Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/210.01
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is four-membered and includes at least one ring nitrogen
Description: Subject matter which contains a heterocyclic ring consisting of four atoms, at least one of which is nitrogen.










Sub-classes under this class:

Class Number Class Name Patents
514/210.19 Additional hetero ring attached directly or indirectly to the four-membered hetero ring by nonionic bonding 94
514/210.02 Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen 191
514/210.17 Having -c(=x)-, wherein x is chalcogen, bonded directly to the four-membered hetero ring 143
514/210.16 Polycyclo ring system having the four-membered hetero ring as one of the cyclos 89


Patents under this class:
1 2 3 4 5

Patent Number Title Of Patent Date Issued
8703721 Arylalkylamine compound and process for preparing the same Apr. 22, 2014
8648118 Bicyclic ring system substituted amide functionalised phenols as medicaments Feb. 11, 2014
8642583 Serotonin receptor modulators Feb. 4, 2014
8637496 Compounds having a monogalactosyldiacylglycerol synthase inhibitory activity as herbicide or algaecide, herbicide and algaecide compositions Jan. 28, 2014
8633182 Indanyloxyphenylcyclopropanecarboxylic acids Jan. 21, 2014
8623860 Azetidine derivatives, pharmaceutical compositions and uses thereof Jan. 7, 2014
8586571 Heterocyclic compound Nov. 19, 2013
8586572 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission Nov. 19, 2013
8551997 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use Oct. 8, 2013
8530461 Azetidine derivatives Sep. 10, 2013
8530460 Azetidine derivatives Sep. 10, 2013
8513229 4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2 Aug. 20, 2013
8492371 Compounds as cannabinoid receptor ligands Jul. 23, 2013
8492111 Arylalkylamine compound and process for preparing the same Jul. 23, 2013
8486929 Combination medicaments for treating bacterial infections Jul. 16, 2013
8445478 Azetidine derivatives, their preparation and their application in therapy May. 21, 2013
8404673 Carbocyclic GlyT1 receptor antagonists Mar. 26, 2013
8389507 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands Mar. 5, 2013
8361998 Compounds and their use as IKACh blockers Jan. 29, 2013
8334282 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Dec. 18, 2012
8309597 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use Nov. 13, 2012
8288368 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells Oct. 16, 2012
8263583 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide Sep. 11, 2012
8247401 P2X.sub.3 receptor antagonists for treatment of pain Aug. 21, 2012
8207155 Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders Jun. 26, 2012
8202513 Aryl potassium channel blockers and uses thereof Jun. 19, 2012
8173631 Cyclic amine compounds May. 8, 2012
8148422 Sulfonamides as TRPM8 modulators Apr. 3, 2012
8119625 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof Feb. 21, 2012
8080541 Carbocyclic GlyT-1 receptor antagonists Dec. 20, 2011
7968534 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors Jun. 28, 2011
7932245 Spirocyclopropyl amides and acids and their therapeutic applications Apr. 26, 2011
7919487 Heteroaryl compounds Apr. 5, 2011
7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives Mar. 15, 2011
7842683 Neurotherapeutic compositions and method Nov. 30, 2010
7790707 S1P receptor modulating compounds and use thereof Sep. 7, 2010
7772223 Carboxamide derivatives as muscarinic receptor antagonists Aug. 10, 2010
7759335 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Jul. 20, 2010
7741316 Pharmacological uses of azetidine derivatives Jun. 22, 2010
7718642 AIDS prophylactic lubricating composition May. 18, 2010
7696191 Crystalline compound Apr. 13, 2010
7691841 Azetidine derivatives as CCR-3 receptor antagonist Apr. 6, 2010
7687489 Agent for treatment of cerebral ischemic diseases Mar. 30, 2010
7687493 Product, method and intermediates for the preparation of azetidine derivatives Mar. 30, 2010
7678808 5 HT receptor mediated neurogenesis Mar. 16, 2010
7666860 Melt-formulated, multi-particulate oral dosage form Feb. 23, 2010
7632820 Avermectin and avemectin monosaccharide derivatives substituted in the 4''- or 4'-position having pesticidal properties Dec. 15, 2009
7544667 Hypocholesterolemic compounds Jun. 9, 2009
7544676 Sulfamoyl benzamides and methods of their use Jun. 9, 2009
7494987 Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient Feb. 24, 2009

1 2 3 4 5










 
 
  Recently Added Patents
Bicycle carrier
Wound dressing with a discontinuous contact layer surface
Snapshots in de-duplication
System for and method of remotely auditing inventoried assets
Grid computing accounting and statistics management system
Nonvolatile semiconductor memory device and method for manufacturing the same
Image decolorizing device
  Randomly Featured Patents
Vacuum apparatus having a pump for discharging liquid therefrom
Sheet processing apparatus
Method of making a cable joint
Active bit line charge keeper
Surface treatment material for a metallic base of an artificial tooth and a surface treatment process using the surface treatment material
Phosphate ester containing photoconductors
Array design using a four state cell for double density
Driven accessory with low-power clutch for activating or de-activating same
Method and apparatus for enforcing memory reference dependencies through a load store unit
Ghost reduction circuit for television receiver